Login / Signup

Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.

Tien-Wei HsuChia-Kuang TsaiYu-Chen KaoTrevor ThompsonAndre F CarvalhoFu-Chi YangPing-Tao TsengChih-Wei HsuChia-Ling YuYu-Kang TuChih-Sung Liang
Published in: BMJ (Clinical research ed.) (2024)
PROSPERO, CRD42023469014.
Keyphrases
  • systematic review
  • meta analyses
  • depressive symptoms
  • major depressive disorder
  • social support
  • combination therapy
  • open label
  • sleep quality
  • clinical trial